AGENUS INC Asset Impairment Charges
AGENUS INC (AGEN) reported Asset Impairment Charges of $234.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AssetImpairmentCharges · last filed 2026-03-16
- AGENUS INC asset impairment charges for the quarter ending 2025-12-31 was $234.00K, a 88.14% decline year-over-year.
- AGENUS INC asset impairment charges for the quarter ending 2025-09-30 was $0.00.
- AGENUS INC asset impairment charges for the quarter ending 2025-06-30 was $0.00.
- AGENUS INC asset impairment charges for the quarter ending 2025-03-31 was $0.00.
- AGENUS INC asset impairment charges for fiscal 2025 was $234.00K, a 88.14% decline from fiscal 2024.
- AGENUS INC asset impairment charges for fiscal 2024 was $1.97M.
- AGENUS INC asset impairment charges for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- AGENUS INC asset impairment charges for fiscal 2022 was $6.11M.
| Period end | Asset Impairment Charges 3 month | Asset Impairment Charges 6 month | Asset Impairment Charges 9 month | Asset Impairment Charges 12 month |
|---|---|---|---|---|
| 2025-12-31 | $234.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $234.00K derived: sum of 2 quarters · filed 2026-03-16 | $234.00K derived: sum of 3 quarters · filed 2026-03-16 | $234.00K 10-K · filed 2026-03-16 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2025-11-10 | $0.00 10-Q · filed 2025-11-10 | $1.97M derived: sum of 4 quarters · filed 2026-03-16 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $0.00 10-Q · filed 2025-08-11 | $1.97M derived: sum of 3 quarters · filed 2026-03-16 | $1.97M derived: sum of 4 quarters · filed 2026-03-16 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-12 | $1.97M derived: sum of 2 quarters · filed 2026-03-16 | $1.97M derived: sum of 3 quarters · filed 2026-03-16 | $1.97M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-12-31 | $1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $1.97M derived: sum of 2 quarters · filed 2026-03-16 | $1.97M derived: sum of 3 quarters · filed 2026-03-16 | $1.97M 10-K · filed 2026-03-16 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | $0.00 derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | $0.00 derived: sum of 3 quarters · filed 2024-08-08 | $0.00 derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-07 | $0.00 derived: sum of 2 quarters · filed 2024-05-07 | $0.00 derived: sum of 3 quarters · filed 2024-05-07 | $0.00 derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $0.00 derived: sum of 2 quarters · filed 2024-03-14 | $0.00 derived: sum of 3 quarters · filed 2024-03-14 | $0.00 10-K · filed 2024-03-14 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | $6.11M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | $6.11M derived: sum of 3 quarters · filed 2025-03-17 | $6.11M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | $6.11M derived: sum of 2 quarters · filed 2025-03-17 | $6.11M derived: sum of 3 quarters · filed 2025-03-17 | $6.11M derived: sum of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | $6.11M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $6.11M derived: sum of 2 quarters · filed 2025-03-17 | $6.11M derived: sum of 3 quarters · filed 2025-03-17 | $6.11M 10-K · filed 2025-03-17 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | $0.00 derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | $0.00 derived: sum of 3 quarters · filed 2022-08-09 | $0.00 derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 | $0.00 derived: sum of 2 quarters · filed 2022-05-10 | $0.00 derived: sum of 3 quarters · filed 2022-05-10 | $0.00 derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | $0.00 10-K · filed 2022-03-01 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | $0.00 derived: sum of 4 quarters · filed 2021-11-09 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $0.00 10-Q · filed 2021-08-09 | $0.00 derived: sum of 3 quarters · filed 2021-08-09 | $0.00 derived: sum of 4 quarters · filed 2021-08-09 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-07 | $0.00 derived: sum of 2 quarters · filed 2021-05-07 | $0.00 derived: sum of 3 quarters · filed 2021-05-07 | $0.00 derived: sum of 4 quarters · filed 2021-05-07 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $0.00 derived: sum of 2 quarters · filed 2021-03-16 | $0.00 derived: sum of 3 quarters · filed 2021-03-16 | $0.00 10-K · filed 2021-03-16 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | $0.00 derived: sum of 4 quarters · filed 2020-11-09 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | $0.00 derived: sum of 3 quarters · filed 2020-08-10 | $0.00 derived: sum of 4 quarters · filed 2020-08-10 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-11 | $0.00 derived: sum of 2 quarters · filed 2020-05-11 | $0.00 derived: sum of 3 quarters · filed 2020-05-11 | $0.00 derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $0.00 derived: sum of 2 quarters · filed 2020-03-16 | $0.00 derived: sum of 3 quarters · filed 2020-03-16 | $0.00 10-K · filed 2020-03-16 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | $0.00 derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $0.00 10-Q · filed 2019-08-09 | $0.00 derived: sum of 3 quarters · filed 2019-08-09 | $0.00 derived: sum of 4 quarters · filed 2019-08-09 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-10 | $0.00 derived: sum of 2 quarters · filed 2019-05-10 | $0.00 derived: sum of 3 quarters · filed 2019-05-10 | $0.00 derived: sum of 4 quarters · filed 2019-05-10 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $0.00 derived: sum of 2 quarters · filed 2019-03-18 | $0.00 derived: sum of 3 quarters · filed 2019-03-18 | $0.00 10-K · filed 2019-03-18 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $0.00 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 | ||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-10 | |||
| 2012-12-31 | $0.00 10-K · filed 2013-03-18 | |||
| 2011-12-31 | $0.00 10-K · filed 2013-03-18 | |||
| 2010-12-31 | $629.38K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |